Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya

Table 4 Provider knowledge of national malaria treatment guidelines in pregnancy comparing respondents from health facilities involved in MFT or MiMBa projects and those not involved

	Overall			Participating in MFT or MiMBa projects			Not Participating in MFT or MiMBa projects			p-value*
	n = 134	%	95% CI	n = 97	%	95% CI	n = 37	%	95% CI	p-value*
Awareness of MTGs	83	62	(53–70)	65	67	(57–76)	18	49	(33–64)	0.08
Training in MiP	66	49	(41–58)	54	56	(46–65)	12	32	(20–48)	0.03
Pregnancy assessment	132	99	(95–100)	96	99	(94–100)	36	97	(86–100)	0.48
Treatment and dosage
1st trimester
Correct drug named	121	90	(84–94)	92	95	(88–98)	29	78	(63–89)	0.01
Correct drug and dosage	48	36	(28–44)	35	36	(27–46)	13	35	(22–51)	1.0
2nd /3rd Trimester
Correct drug named	113	84	(77–90)	89	92	(85–96)	24	65	(49–78)	< 0.001
Correct drug and dosage	48	36	(28–44)	32	33	(24–43)	16	43	(29–59)	0.37
Severe MiP
Correct drug named	126	94	(89–97)	91	94	(87–97)	35	95	(82–99)	1.0
Correct drug and dosage	73	54	(46–63)	53	55	(45–64)	20	54	(38–69)	1.0
Adequate knowledge**
Correct drug and dosage	14	10	(6–17)	10	10	(6–18)	4	11	(4–25)	1.0
Parasitological diagnosis and correct drug with dosage	13	10	(6–16)	9	9	(5–17)	4	11	(4–25)	0.74

*Fisher exact used for strata with < 5 observations. Acronyms: MFT, multiple first-line therapies, MTG, malaria treatment guidelines, MiP, malaria in pregnancy, Tri, trimester of pregnancy
**correct drug and dosage for uncomplicated malaria in all trimesters and complicated malaria

ISSN: 1475-2875